CVM
Price
$1.41
Change
+$0.10 (+7.63%)
Updated
Nov 3 closing price
Capitalization
24.8M
49 days until earnings call
Intraday BUY SELL Signals
MDGL
Price
$396.32
Change
-$34.83 (-8.08%)
Updated
Nov 3 closing price
Capitalization
9.16B
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CVM vs MDGL

CVM vs MDGL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CVM vs. MDGL commentary
Nov 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVM is a Hold and MDGL is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CVM with price predictions
Nov 03, 2026

Momentum Indicator for CVM turns negative, indicating new downward trend

CVM saw its Momentum Indicator move below the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned negative. In 90 of the 97 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CVM turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 37 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

CVM moved below its 50-day moving average on October 19, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CVM crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for CVM entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CVM's RSI Oscillator exited the oversold zone, 31 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVM advanced for three days, in 175 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

CVM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. CVM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.264) is normal, around the industry mean (3.051). P/E Ratio (-0.834) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.370) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for MDGL with price predictions
Nov 03, 2026

MDGL's RSI Oscillator is remaining in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDGL advanced for three days, in 219 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

MDGL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 50-day moving average for MDGL moved below the 200-day moving average on October 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDGL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for MDGL entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.484) is normal, around the industry mean (3.051). P/E Ratio (-28.329) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. P/S Ratio (9.443) is also within normal values, averaging (439.647).

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 28 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. MDGL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
CVM vs MDGL: Fundamental Ratings
CVM
MDGL
OUTLOOK RATING
1..100
6953
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
10028
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8363
P/E GROWTH RATING
1..100
5120
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDGL's Valuation (18) in the Pharmaceuticals Other industry is significantly better than the same rating for CVM (98) in the Biotechnology industry. This means that MDGL’s stock grew significantly faster than CVM’s over the last 12 months.

MDGL's Profit vs Risk Rating (28) in the Pharmaceuticals Other industry is significantly better than the same rating for CVM (100) in the Biotechnology industry. This means that MDGL’s stock grew significantly faster than CVM’s over the last 12 months.

MDGL's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as CVM (100) in the Biotechnology industry. This means that MDGL’s stock grew similarly to CVM’s over the last 12 months.

MDGL's Price Growth Rating (63) in the Pharmaceuticals Other industry is in the same range as CVM (83) in the Biotechnology industry. This means that MDGL’s stock grew similarly to CVM’s over the last 12 months.

MDGL's P/E Growth Rating (20) in the Pharmaceuticals Other industry is in the same range as CVM (51) in the Biotechnology industry. This means that MDGL’s stock grew similarly to CVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVMMDGL
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 19 days ago
79%
Bullish Trend 8 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 12 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
70%
COMPARISON
Comparison
Nov 04, 2026
Stock price -- (CVM: $1.41 vs. MDGL: $396.32)
Brand notoriety: CVM: Notable vs. MDGL: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 112% vs. MDGL: 750%
Market capitalization -- CVM: $24.8M vs. MDGL: $9.16B
CVM [@Biotechnology] is valued at $24.8M. MDGL’s [@Biotechnology] market capitalization is $9.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $134.53B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green while MDGL’s FA Score has 3 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 3 green, 2 red.
According to our system of comparison, MDGL is a better buy in the long-term than CVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 4 TA indicator(s) are bullish while MDGL’s TA Score has 4 bullish TA indicator(s).

  • CVM’s TA Score: 4 bullish, 6 bearish.
  • MDGL’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than CVM.

Price Growth

CVM (@Biotechnology) experienced а -10.19% price change this week, while MDGL (@Biotechnology) price change was -9.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.09%. For the same industry, the average monthly price growth was -12.05%, and the average quarterly price growth was -17.02%.

Reported Earning Dates

CVM is expected to report earnings on Dec 23, 2026.

MDGL is expected to report earnings on Feb 25, 2027.

Industries' Descriptions

@Biotechnology (-2.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CVM
Daily Signal:
Gain/Loss:
MDGL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with ALXO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then ALXO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-8.08%
ALXO - MDGL
56%
Loosely correlated
-5.84%
IPHA - MDGL
44%
Loosely correlated
-4.32%
LCTX - MDGL
43%
Loosely correlated
N/A
CVM - MDGL
43%
Loosely correlated
+7.63%
VOR - MDGL
42%
Loosely correlated
+3.17%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BCHP37.560.32
+0.86%
Principal Focused Blue Chip ETF (BCHP)
BMED36.280.18
+0.49%
iShares Health Innovation Active ETF (BMED)
CGGR45.670.21
+0.46%
Capital Group Growth ETF (CGGR)
AOK40.46-0.12
-0.30%
iShares Core 30/70 Conservative Allocation ETF (AOK)
EFAD45.73-0.44
-0.95%
ProShares MSCI EAFE Dividend Growers ETF (EFAD)